17971074|t|The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease.
17971074|a|Semicarbazide-sensitive amine oxidase (SSAO) catalyses the oxidative deamination of a variety of endogenous substrates, such as methylamine and aminoacetone, to produce highly reactive aldehydes, which are capable of inducing protein cross-linkage, beta amyloid (Abeta) aggregation and advanced glycation end-product formation. In the brain, SSAO is exclusively located on the blood vessels. Deposits of Abeta, the hallmark of Alzheimer's disease (AD), are closely associated with cerebral blood vessels, that is, cerebral amyloid angiopathy (CAA). In the present study, we examined whether SSAO-mediated deamination contributes to CAA in AD. We employed immunohistochemistry to examine the colocalization of SSAO and Abeta in post mortem brains of AD patients. To assess the role of SSAO-mediated deamination in the deposition of Abeta on blood vessel walls, we developed an in vitro blood vessel model using sections of human umbilical cord. We found a strong expression of SSAO colocalized with Abeta deposits on the blood vessels in AD brains. We also demonstrated that SSAO-mediated deamination increases the deposition of Abeta onto blood vessel walls. Our results support the hypothesis that cerebral vascular SSAO-catalysed deamination contributes to CAA in AD brains.
17971074	38	75	semicarbazide-sensitive amine oxidase	Gene	314
17971074	79	106	cerebral amyloid angiopathy	Disease	MESH:D016657
17971074	110	129	Alzheimer's disease	Disease	MESH:D000544
17971074	131	168	Semicarbazide-sensitive amine oxidase	Gene	314
17971074	170	174	SSAO	Gene	314
17971074	259	270	methylamine	Chemical	MESH:C027451
17971074	275	287	aminoacetone	Chemical	MESH:C006495
17971074	316	325	aldehydes	Chemical	MESH:D000447
17971074	394	399	Abeta	Gene	351
17971074	417	447	advanced glycation end-product	Disease	MESH:D003643
17971074	473	477	SSAO	Gene	314
17971074	535	540	Abeta	Gene	351
17971074	558	577	Alzheimer's disease	Disease	MESH:D000544
17971074	579	581	AD	Disease	MESH:D000544
17971074	645	672	cerebral amyloid angiopathy	Disease	MESH:D016657
17971074	674	677	CAA	Disease	MESH:D016657
17971074	722	726	SSAO	Gene	314
17971074	763	766	CAA	Disease	MESH:D016657
17971074	770	772	AD	Disease	MESH:D000544
17971074	840	844	SSAO	Gene	314
17971074	849	854	Abeta	Gene	351
17971074	880	882	AD	Disease	MESH:D000544
17971074	883	891	patients	Species	9606
17971074	915	919	SSAO	Gene	314
17971074	962	967	Abeta	Gene	351
17971074	1053	1058	human	Species	9606
17971074	1107	1111	SSAO	Gene	314
17971074	1129	1134	Abeta	Gene	351
17971074	1168	1170	AD	Disease	MESH:D000544
17971074	1205	1209	SSAO	Gene	314
17971074	1259	1264	Abeta	Gene	351
17971074	1348	1352	SSAO	Gene	314
17971074	1390	1393	CAA	Disease	MESH:D016657
17971074	1397	1399	AD	Disease	MESH:D000544
17971074	Association	MESH:D000544	314
17971074	Positive_Correlation	MESH:C006495	MESH:D000447
17971074	Association	314	351
17971074	Association	MESH:D003643	314
17971074	Association	MESH:D016657	314
17971074	Association	MESH:D000544	351
17971074	Positive_Correlation	MESH:D000447	MESH:D003643
17971074	Positive_Correlation	MESH:C027451	MESH:D000447
17971074	Association	MESH:D016657	351

